Article Sidebar

PDF
Date Published: 30/03/2023
Abstract Views: 374
Views PDF: 305
DOI: https://doi.org/10.51298/vmj.v524i2.4697
Issue
Vol. 524 No. 2 (2023)
Section
Các bài báo
How to Cite
Trần , Q. H. ., & Trần , T. T. . (2023). RESULTS OF RETROPERITONEAL LAPAROSCOPIC FOR UPPER URINARY TRACT CANCER AT HANOI MEDICAL UNIVERSITY HOSPITAL. Vietnam Medical Journal, 524(2). https://doi.org/10.51298/vmj.v524i2.4697

RESULTS OF RETROPERITONEAL LAPAROSCOPIC FOR UPPER URINARY TRACT CANCER AT HANOI MEDICAL UNIVERSITY HOSPITAL

Quốc Hòa Trần 1,2,, Trung Thành Trần 1,2
1 Hanoi medical university hospital
2 Hanoi medical university

Main Article Content

Abstract

Surgical treatment is a key role in the treatment of the upper urinary tract cancer. For many years, Hanoi Medical University Hospital has performed retroperitoneal laparoscopic nephrectomy combined with open surgical resection of the distal ureter and bladder cone to treat many cases of the upper urinary tract cancer. Our study included 40 patients with the upper urinary tract cancer, including 28 retrospective and 12 prospective patients undergoing surgery and follow-up from 2010 to 2022. Method is longitudinal follow-up descriptive study with non-probability convenience sample. Results: The mean age of the patients in the study was 62.6 ± 12.35. Men make up the majority with 72.5%. The mean total surgical time was 136.4 ± 28.04 minutes. The mean hospital stay was 7.4 ± 1.92 days. There were 4 patients who required blood transfusion immediately after surgery. No patient had a complication greater than grade 1 according to the Clavien-Dindo classification. There were 2 cases of patients with bladder recurrence within 1 month after surgery. The survival time calculated according to the Kaplan-Meier method: from 0 to 11 months is 100%, from 12 to 23 months is 70%, from 24 to 35 months is 47.5% and from 36 months or more is 12.5%.

Article Details

Keywords

upper urinary tract cancer, retroperitoneal laparoscopic

References

1. Rouprêt M, Babjuk M, Compérat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013; 63(6):1059-1071.
2. Liu JY, Dai YB, Zhou FJ, et al. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicentre study. BMC Surg. 2017; 17(1):8.
3. Liu Wentao, Wang Yinhuai, Zhong Zhaohui, et al. Transperitoneal versus retroperitoneal laparoscopic nephroureterectomy in the management of upper urinary tract urothelial carcinoma: a matched-pair comparison based on perioperative outcomes. Surgical Endoscopy. 2016; 30(12):5537–5541.
4. Keiichiro Mori, Florian Janisch, Mehdi Kardoust Pariz, et al. Prognostic Value of Variant Histology in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Systematic Review and Meta-Analysis. American Urological Association Education And Research. 2020; 203:1075-1084.
5. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016; 66(1):7–30.
6. Shariat SF, Favaretto RL, Gupta A, et al. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011; 29:481–486.
7. Campi Riccardo, Cotte Juliette, Sessa Francesco, et al. Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience. World Journal of Urology. 2019; 37(11):2303-2311.
8. Abe T, Shinohara N, Muranaka M, et al. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multiinstitutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Eur J Surg Oncol. 2010; 36(11):1085–1091.
9. Lughezzani G, Jeldres C, Isbarn H, et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology. 2010; 75(1):118–124.
10. Kamihira O, Hattori R, Yamaguchi A, et al. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol. 2009; 55(6):1397–1407.